Safety signaling is a key scientific disipline that often gets overlooked in personal injury case involving pharmacetutical or medical device products. John Clark and I recently published an article on this topic in the Defense Research Institute’s (DRI’s) quarterly publication, Rx For the Defense.

In this piece, we address two important questions related to adverse event reporting: (1) whether or not the manufacturer had a duty to warn; and (2) if so, what was the time point at which a safety issue could/should have become known by the Company.